Literature DB >> 16835379

Endogenous thrombospondin-1 is a cell-surface ligand for regulation of integrin-dependent T-lymphocyte adhesion.

Shu Shun Li1, Zhiwen Liu, Mehmet Uzunel, Karl-Gösta Sundqvist.   

Abstract

Lymphocyte adhesion to cells and extracellular matrix (ECM) via integrins plays a pivotal role for the function of the immune system. We show here that endogenous thrombospondin-1 (TSP-1) is a cell-surface ligand for cis interaction of surface receptors in T lymphocytes controlled by integrins and the T-cell antigen receptor (TCR/CD3). Stimulation of CD3 triggers rapid surface expression of TSP-1 in quiescent T cells, whereas activated cells express TSP-1 constitutively. Endogenous TSP-1 is attached to lipoprotein receptor-related protein 1 (LRP1/CD91) and calreticulin (CRT) on the cell surface through its NH2-terminal domain. Adhesion via integrins to ICAM-1 or ECM components up-regulates TSP turnover dramatically from a low level in nonadherent cells, whereas CD3 stimulation inhibits TSP turnover through interference with CD91/CRT-mediated internalization. Integrin-associated protein (IAP/CD47) is essential for TSP turnover and adhesion through interaction with the C-terminal domain of TSP-1 in response to triggering signals delivered at the NH2-terminal. These results indicate that endogenous TSP-1 connects separate cell-surface receptors functionally and regulates T-cell adhesion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16835379     DOI: 10.1182/blood-2006-04-016832

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  38 in total

1.  Antigen-induced regulation of T-cell motility, interaction with antigen-presenting cells and activation through endogenous thrombospondin-1 and its receptors.

Authors:  Sten-Erik Bergström; Mehmet Uzunel; Toomas Talme; Eva Bergdahl; Karl-Gösta Sundqvist
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

Review 2.  The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47.

Authors:  David D Roberts; Thomas W Miller; Natasha M Rogers; Mingyi Yao; Jeffrey S Isenberg
Journal:  Matrix Biol       Date:  2012-01-14       Impact factor: 11.583

3.  DLL4/Notch1 and BMP9 Interdependent Signaling Induces Human Endothelial Cell Quiescence via P27KIP1 and Thrombospondin-1.

Authors:  Bahman Rostama; Jacqueline E Turner; Guy T Seavey; Christine R Norton; Thomas Gridley; Calvin P H Vary; Lucy Liaw
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-15       Impact factor: 8.311

4.  CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation.

Authors:  Kavya Rakhra; Pavan Bachireddy; Tahera Zabuawala; Robert Zeiser; Liwen Xu; Andrew Kopelman; Alice C Fan; Qiwei Yang; Lior Braunstein; Erika Crosby; Sandra Ryeom; Dean W Felsher
Journal:  Cancer Cell       Date:  2010-10-28       Impact factor: 31.743

Review 5.  An essential role for the immune system in the mechanism of tumor regression following targeted oncogene inactivation.

Authors:  Stephanie C Casey; Yulin Li; Dean W Felsher
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

6.  Tumor dormancy, oncogene addiction, cellular senescence, and self-renewal programs.

Authors:  David I Bellovin; Bikul Das; Dean W Felsher
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

7.  Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation.

Authors:  Thomas W Miller; Sukhbir Kaur; Kelly Ivins-O'Keefe; David D Roberts
Journal:  Matrix Biol       Date:  2013-03-13       Impact factor: 11.583

8.  Deficiency of thrombospondin-1 reduces Th17 differentiation and attenuates experimental autoimmune encephalomyelitis.

Authors:  Kaiyong Yang; Jose L Vega; Muhamed Hadzipasic; Jean Pierre Schatzmann Peron; Bing Zhu; Yijun Carrier; Sharmila Masli; Luiz Vicente Rizzo; Howard L Weiner
Journal:  J Autoimmun       Date:  2009-02-01       Impact factor: 7.094

9.  Aberrant methylation of thrombospondin-1 and its association with reduced expression in gastric cardia adenocarcinoma.

Authors:  Wei Guo; Zhiming Dong; Ming He; Yanli Guo; Jianwen Guo; Zhifeng Chen; Zhibin Yang; Gang Kuang
Journal:  J Biomed Biotechnol       Date:  2010-03-15

10.  A cytokine-controlled mechanism for integrated regulation of T-lymphocyte motility, adhesion and activation.

Authors:  Sten-Erik Bergström; Eva Bergdahl; Karl-Gösta Sundqvist
Journal:  Immunology       Date:  2013-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.